Substance P is associated with heart enlargement and apoptosis in murine dilated cardiomyopathy induced by Taenia crassiceps infection

Journal of Parasitology

Volumn 93, Issue 5, 2007, Pages 1121-1127

  D'Souza, Melinda ^a   Garza, M Armandina ^a   Xie, Min ^a   Weinstock, Joel ^a,b   Xiang, Qian ^a   Robinson, Prema ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SUBSTANCE P;

APOPTOSIS; CARDIOVASCULAR DISEASE; FLATWORM; GENETIC ENGINEERING; IMMUNOASSAY; MUSCLE; PATHOGENICITY; RODENT;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY WEIGHT; CARDIOMEGALY; CARDIOMYOPATHY; CELL SIZE; CONTROLLED STUDY; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART MUSCLE CELL; HEART VENTRICLE WALL; HEART WEIGHT; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PARASITOSIS; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE; TAENIA CRASSICEPS; TAENIASIS; WILD TYPE;

ANIMALS; APOPTOSIS; CARDIOMEGALY; CARDIOMYOPATHY, DILATED; CYSTICERCOSIS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIUM; NEUROTRANSMITTER AGENTS; SUBSTANCE P; TAENIA; TAENIASIS;

ANIMALIA; BACTERIA (MICROORGANISMS); MURINAE; MUS; TAENIA CRASSICEPS;

EID: 36749032243     PISSN: 00223395     EISSN: None     Source Type: Journal    
DOI: 10.1645/GE-596R1.1     Document Type: Article

References (43)

1. ALVAREZ, J., D. P. LONDONO, A. L. ALVAREZ, J. TRUJILLO, M. M. JARAMILLO, AND B. I. RESTREPO. 2002. Granuloma formation and parasite disintegration in porcine cysticercosis: comparison with human neurocysticercosis. Journal of Comparative Pathology 127: 186-193.
2. AMOSOVA, E. N., Y. V. SHPAK, A. V. NEDOZHDIJ, AND L. V. PRODUSEVICH. 2004. Proinflammatory cytokine levels in patients with diastolic heart failure. Kardiologia Polska 61: 17-20.
3. ANKERSMIT, H., B. MOSER, A. ZUCKERMANN, G. ROTH, S. TAGHAVI, M. BRUNNER, E. WOLNER, AND G. BOLTZ-NITULESCU. 2002. Activation-induced T cell death, and aberrant T cell activation via TNFR1 and CD95-CD95 ligand pathway in stable cardiac transplant recipients. Clinical Experimental Immunology 128: 175-180.
4. BEDARD, K., AND B. L. SEMLER. 2004. Regulation of Picornavirus gene expression. Microbes and Infection 6: 702-713.
5. BLUM, A. M., A. METWALI, M. KIM-M ILLER, J. LI, K. QADIR, D. E. ELLIOTT, B. LU, Z. FABRY, N. GERARD, AND J. V. WEINSTOCK. 1999. The substance P receptor is necessary for a normal granulomatous response in murine schistosomiasis mansoni. Journal of Immunology 162: 6080-6085.
6. CHURCH, D., S. J. ARKINSTALL, M. B. VALLOTTON, A. CHOLLET, E. KAWASHIMA, AND U. LANG. 1996. Stimulation of atrial natriuretic peptide release by neurokinins in neonatal rat ventricular cardiomyocytes. American Journal of Physiology 270: H935-H944.
7. COOK, G. A., D. ELLIOTT, A. METWALI, A. M. BLUM, M. SANDOR, R. LYNCH, AND J. V. WEINSTOCK. 1994. Molecular evidence that granuloma T lymphocytes in murine schistosomiasis mansoni express an authentic substance P (NK-1) receptor. Journal of Immunology 152: 1830-1835.
8. CRUZ, M. E., P. M. SCHANTZ, I. CRUZ, P. ESPINOSA, P. M. PREUX, A. CRUZ, W. BENITEZ, V. C. TSANG, J. FERMOSO, AND M. DUMAS. 1999. Epilepsy and neurocysticercosis in an Andean community. International Journal of Epidemiology 28: 799-803.
9. CUESTA, M. C., L. QUINTERO, H. PONS, AND H. SUAREZ-ROCA. 2002. Substance P and calcitonin gene-related peptide increase IL-1 beta, IL-6 and TNF alpha secretion from human peripheral blood mononuclear cells. Neurochemistry International 40: 301.
10. CUTRONE, J., D. GEORGIOU, K. GIL-GOMEZ, AND B. H. BRUNDAGE. 1995. Myocardial cysticercosis detected by ultrafast CT Chest 108: 1752-1754.
11. ECKART, R., S. L. SCOVILLE, C. L. CAMPBELL, E. A. SHRY, K. C. STAJDUHAR, R. N. POTTER, L. A. PEARSE, AND R. VIRMANI. 2004. Sudden death in young adults: A 25-year review of autopsies in military recruits. Annals of Internal Medicine 141: 829-834.
12. FIEBICH, B. L., S. SCHLEICHER, R. D. BUTCHER, A. CRAIG, AND K. LIEB. 2000. The neuropeptide substance P activates p38 mitogen-activated protein kinase resulting in IL-6 expression independently from NF-kappa B. Journal of Immunology 165: 5606.
13. GOODE, T., J. O'CONNELL, C. STERNINI, P. ANTON, H. WONG, G. C. O'SULLIVAN, J. K. COLLINS, AND F. SHANAHAN. 1998. Substance P (neurokinin-1) receptor is a marker of human mucosal but not peripheral mononuclear cells: molecular quantitation and localization. Journal of Immunology 161: 2232-2240.
14. GREAVES, K., J. S. OXFORD, C. P. PRICE, G. H. CLARKE, AND T. CRAKE. 2003. The prevalence of myocarditis and skeletal muscle injury during acute viral infection in adults: Measurement of cardiac troponins I and T in 152 patients with acute influenza infection. Archives of Internal Medicine 163: 165-168.
15. GROZDEV, L., D. KAFTANDZIEV, D. ROGANOVIC, AND V. COLANCESKI. 1980. Pathomorphologic and ultrastructural characteristics of endocardial Cysticercus cellulosae. ACTA Chirurgica Iugoslavica 27: 11-20.
16. HO, W. Z., J. P. LAI, X. H. ZHU, M. UVAYDOVA, AND S. D. DOUGLAS. 1997. Human monocytes and macrophages express substance P and neurokinin-1 receptor. Journal of Immunology 159: 5654-5660.
17. HONORE, P., S. D. ROGERS, M. J. SCHWEI, J. L. SALAK-JOHNSON, N. M. LUGER, M. C. SABINO, D. R. CLOHISY, AND P. W. MANTYH. 2000. Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons. Neuroscience 98: 585-598.
18. IWASAKI, A., A. MATSUMORI, T. YAMADA, T. SHIOI, W. WANG, K. ONO, R. NISHIO, M. OKADA, AND S. SASAYAMA. 1999. Pimobendan inhibits the production of proinflammatory cytokines and gene expression of inducible nitric oxide synthase in a murine model of viral myocarditis. Journal of the American College of Cardiology 33: 1400-1407.
19. KITAURA, Y., H. DEGUCHI, F. TERASAKI, A. UKIMURA, H. MORITA, AND T. TATSUMI. 2003. Influenza myocarditis - Pathophysiology and developmental mechanism of myocarditis. Nippon Rinsho, Japanese Journal of Clinical Medicine 61: 1945-1952.
20. KUNZ, J., B. KALINNA, V. WATSCHKE, AND E. GEYER. 1989. Taenia crassiceps metacestode vesicular fluid antigens shared with the Taenia solium larval stage and reactive with serum antibodies from patients with neurocysticercosis. Zentralblatt Fur Bakteriologie 271: 510-520.
21. LARRALDE, C., R. M. MONTOYA, J. SOTELO, J. HAYUNGA, E. SCIUTTO, G. PALENCIA, A. PADILLA, T. GOVENSKY, AND M. L. DIAZ. 1990. Murine T. crassiceps antigens in immunodiagnosis of T. solium human neurocysticercosis, T. saginata bovine cysticercosis, and human E. granulosus hydatidosis. Bulletin de la Societe Francaise de Parasitology 8: S8B.
22. LIEB, K., H. SCHALLER, J. BAUER, M. BERGER, K. SCHULZE-OSTHOFF, AND B. L. FIEBICH. 1998. Substance P and histamine induce interleukin-6 expression in human astrocytoma cells by a mechanism involving protein kinase C and nuclear factor-IL-6. Journal of Neurochemistry 70: 1577.
23. LINO, J. R. S., P. M. RIBEIRO, E. J. ANTONELLI, A. C. FALEIROS, S. A. TERRA, M. A. REIS, AND V. P. TEIXEIRA. 2002. Developmental characteristics of Cysticercus cellulosae in the human brain and heart. Revista da Sociedade Brasileira de Medicina Tropical 35: 617-622.
24. _, M. A. REIS, AND V. P. TEIXEIRA. 1999. Occurrence of encephalic and cardiac cysticercosis (Cysticercus cellulosae) in necropsy. Revista de Saude Publica 33: 495-498.
25. LOTZ, M., J. H. VAUGHAN, AND D. A. CARSON. 1988. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 241: 1218-1221.
26. MAGGI, C. A. 1997. The effects of tachykinins on inflammatory and immune cells. Regulatory Peptides 70: 75-90.
27. MATSUMORI, A., AND S. SASAYAMA. 1995. Immunomodulating agents for the management of heart failure with myocarditis and cardiomyopathy - Lessons from animal experiments. European Heart Journal Supplement O: 140-143.
28. MCGOWAN, B., E. F. CICCIMARO, T. O. CHAN, AND A. M. FELDMAN. 2003. The balance between pro-apoptotic and anti-apoptotic pathways in the failing myocardium. Cardiovascular Toxicology 3: 191-206.
29. MEDINA, M. T., E. ROSAS, F. RUBIO- DONNADIEU, AND J. SOTELO. 1990. Neurocysticercosis as the main cause of late-onset epilepsy in Mexico. Archives of Internal Medicine 150: 325-327.
30. MURTHY, J. M., AND R. YANGALA. 1998. Etiological spectrum of symptomatic localization related epilepsies: a study from South India. Journal of the Neurological Sciences 158: 65-70.
31. NIAKARA, A., R. CISSE, A. TRAORE, P. A. NIAMBA, F. BARRO, AND J. KABORE. 2002. Myocardial localization of a disseminated cysticercosis. Echocardiographic diagnosis of a case. Archives des Maladies du Coeur et des Vaisseux 95: 606-608.
32. PARISSIS, J., S. ADAMOPOULOS, A. RIGAS, G. KOSTAKIS, D. KARATZAS, K. VENETSANOU, AND D. T. KREMASTINOS. 2004. Comparison of circulating proinflammatory cytokines and soluble apoptosis mediators in patients with chronic heart failure with versus without symptoms of depression. American Journal of Cardiology 94: 1326-1328.
33. ROBINSON, P., A. C. WHITE, D. E. LEWIS, J. THORNBY, E. DAVID, AND J. WEINSTOCK. 2002. Sequential expression of the neuropeptides substance P and somatostatin in granulomas associated with murine cysticercosis. Infection and Immunity 70: 4534-4538.
34. RULLAN, E., AND L. H. SIGAL. 2001. Rheumatic fever. Current Rheumatology Reports 3: 445-452.
35. SCIUTTO, E., G. FRAGOSO, M. BACA, V. DE LA CRUZ, L. LEMUS, AND E. LAMOYI. 1995. Depressed T-cell proliferation associated with susceptibility to experimental Taenia crassiceps infection. Infection and Immunity 63: 2277-2281.
36. SETSUTA, K., Y. SEINO, T. OGAWA, T. OHTSUKA, K. SEIMIYA, AND T. TAKANO. 2004. Ongoing myocardial damage in chronic heart failure is related to activated tumor necrosis factor and Fas/Fas ligand system. Circulation 68: 747-750.
37. SONG, W., X. LU, AND Q. FENG. 2000. Tumor necrosis factor-alpha induces apoptosis via inducible nitric oxide synthase in neonatal mouse cardiomyocytes. Cardiovascular Research 45: 595-602.
38. SUZUKI, K., B. MURTUZA, R. T. SMOLENSKI, I. A. SAMMUT, N. SUZUKI, Y. KANEDA, AND M. H. YACOUB. 2001. Overexpression of interleukin-1 receptor antagonist provides cardioprotection against ischemia-reperfusion injury associated with reduction in apoptosis. Circulation 104: 1308-1313.
39. VERONESI, B., J. D. CARTER, R. B. DEVLIN, S. A. SIMON, AND M. OORTGIESEN. 1999. Neuropeptides and capsaicin stimulate the release of inflammatory cytokines in a human bronchial epithelial cell line. Neuropeptides 33: 447-456.
40. VILLA, O. F., AND R. E. KUHN. 1996. Mice infected with the larvae of Taenia crassiceps exhibit a Th2-like immune response with concomitant anergy and downregulation of Th1- associated phenomena. Parasitology 112: 561-570.
41. VINAS, A. P., S. V. LAREDO, M. B. TERRAZAS, AND J. R. COURA. 2003. Dilated cardiomyopathy in patients with chronic chagasic infection: Report of two fatal autochthonous cases from Rio Negro, State of Amazonas, Brazil. Revista da Sociedade Brasileira de Medicina Tropical 36: 401-407.
42. WEINSTOCK, J. V., AND D. ELLIOTT. 1998. The substance P and somatostatin interferon-gamma immunoregulatory circuit. Annals of the New York Academy of Sciences 840: 532-539.
43. WHITE, A. C. JR. 2000. Neurocysticercosis: updates on epidemiology, pathogenesis, diagnosis, and management. Annual Review of Medicine 51: 187-206.